This finding was also supported by a study using amyloid and tau PET imaging,59 which observed that plasma t‐tau levels were elevated in amyloid PET–positive DS individuals compared to amyloid PET–negative euploid controls, while no significant difference in plasma t‐tau levels was found in amyloid PET–negative DS individuals. The gene discussed is MAPT; the disease is Dravet syndrome.